Inhibrx Biosciences Inc. (INBX)
undefined
undefined%
At close: undefined
14.62
0.07%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Revenue 1.80M 2.18M 7.13M 12.81M 9.09M 7.50M 7.95M 6.67M
Cost of Revenue 1.19M 2.85M 2.69M 73.50M 47.91M 33.45M 25.51M 16.99M
Gross Profit 609.00K -668.00K 4.44M -60.69M -38.81M -25.95M -17.56M -10.32M
Operating Income -219.22M -129.12M -76.56M -67.44M -43.71M -29.51M -19.73M -12.15M
Interest Income 11.92M 16.11M 5.22M 10.82M 5.72M - - 759.00K
Pretax Income -239.72M -145.22M -81.77M -75.63M -50.50M -30.93M -21.83M -12.88M
Net Income -241.36M -145.23M -81.77M -75.64M -51.40M -31.16M -19.44M -8.27M
Selling & General & Admin 29.38M 21.12M 12.36M 6.84M 9.02M 4.65M 2.61M 1.57M
Research & Development 191.64M 110.19M 71.44M 73.50M 47.91M 33.45M 25.51M 16.99M
Other Expenses - -14.00K -106.00K -80.00K -4.12M 68.00K 24.00K -
Operating Expenses 219.83M 131.29M 83.69M 80.25M 52.81M 37.01M 27.68M 18.56M
Interest Expense 31.84M 16.11M 5.22M 10.82M 5.72M 1.48M 2.13M -
Selling & Marketing Expenses - - - - - - - -253.00K
Cost & Expenses 221.02M 131.29M 83.69M 80.25M 52.81M 37.01M 27.68M 18.81M
Income Tax 3.00K 3.00K 2.00K 3.00K 898.00K 96.00K 250.00K -4.62M
Shares Outstanding (Basic) 47.13M 40.11M 38.01M 25.26M 36.55M 27.08M 28.79M 36.55M
Shares Outstanding (Diluted) 47.13M 40.11M 38.01M 25.26M 36.55M 27.08M 28.79M 36.55M
EPS (Basic) -5.12 -3.62 -2.15 -2.99 -1.41 -1.15 -0.68 -0.23
EPS (Diluted) -5.12 -3.62 -2.15 -2.99 -1.41 -1.15 -0.68 -0.23
EBITDA -206.69M -125.82M -76.56M -67.44M -42.60M -28.77M -19.30M -11.89M
Depreciation & Amortization 1.19M 1.23M 2.69M 2.39M 2.52M 676.00K 399.00K 253.00K